Healthcare Industry News: NuCore
News Release - January 5, 2007
Spine Wave Board of Directors Adds Jerry Elliott, Chief Executive Officer of Global SignalSHELTON, CT--(Healthcare Sales & Marketing Network)--Jan 5, 2007 -- Spine Wave, Inc., a company focused on the development and marketing of innovative spinal surgery solutions, announced today the election of Jerry Elliott to its Board of Directors and to the role of Audit Committee Chairman.
"We are delighted to have Jerry join our Board," said Mark LoGuidice, Chairman and Chief Executive Officer of Spine Wave. "Jerry has a unique mix of operating, financial and legal experience, which he has used to create substantial value in both the public and private markets. His insights will be invaluable as we build the Company in the years to come."
Mr. Elliott is the CEO, President and a member of the Board of Directors of Global Signal, Inc. (NYSE:GSL ), a company providing towers and communication sites to the wireless communications industry. Global Signal is in the process of a merger valued at $5.8B with Crown Castle International. Prior to joining Global Signal, Jerry was President and a member of the Board of Directors of Citizens Communications. Mr. Elliott was also Managing Director in Morgan Stanley's Media and Communications Investment Banking Group. He received his B.B.A. in Accounting and Finance and a J.D. from Baylor University, and an L.L.M. in Taxation from New York University School of Law.
"Spine Wave's management team, with its truly innovative spinal technologies, is well positioned to revolutionize spinal surgery," said Elliott. "I am excited to begin working with Mark and the Board as the Company brings these technologies to spine surgeons and their patients."
About Spine Wave
Spine Wave, Inc., headquartered in Shelton, Connecticut, is a medical device company focused on the development of clinical solutions for three of the largest and fastest growing spinal market segments: nuclear replacement and augmentation, vertebral compression fracture repair and spinal fusion. The Company's product portfolio includes the NuCore™ Injectable Nucleus, the StaXx™ FX Fracture Repair System, the StaXx™ XD Expandable Device, and several additional products in development. For more information, visit Spine Wave's website at www.SpineWave.com.
This information is intended for media professionals and investors.
Source: Spine Wave
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.